Patient Experience from Prolia | Osteoporosis | Amgen

PROLIA® IS AN EFFECTIVE AND WELL TOLERATED THERAPY FOR THE LONG-TERM MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS1

These patients can benefit from Prolia®*
Active woman suffering from wrist fracture.
Woman with diagnosed osteoporosis and reflux disease.
Woman with comorbidities and poor persistence with medication.
Woman who has been receiving Prolia for 3 years.

References:
*Theoretical patient cases.
  1. Bone HG, et al. Lancet Endocrinol Diabetes. 2017;5:513–23.

SMPC

The information contained in this site is for healthcare professionals only

I am a patient
I am a member of the public